Brief: Suven Life Sciences Dec Qtr Consol Net Profit Rises
Feb 13 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* SUVEN LIFE SCIENCES LTD -DECLARED AN INTERIM DIVIDEND OF
2.50
RUPEES PER SHARE
* DEC QUARTER CONSOL NET PROFIT 579.1 MILLION RUPEES VERSUS
344.5
MILLION RUPEES YEAR AGO
* DEC QUARTER CONSOL REVENUE FROM OPERATIONS 1.79 BILLION
RUPEES
VERSUS 1.27 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSEbKJrY9
Further company coverage: SUVP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees